ArticleWorld journal of clinical oncology2025
Programmed cell death 1 inhibitor sintilimab plus S-1 and gemcitabine for liver metastatic pancreatic ductal adenocarcinoma.
Shi-Qiong Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.